Validation of Clinicoradiological Criteria for the Diagnosis of Cerebral Amyloid Angiopathy-Related Inflammation
JAMA Neurol 73:197-202, Auriel, E.,et al, 2016
Clinicopathologic Conference, Susacs Syndrome (retinocochleocerebral vasculopathy)
NEJM 365:549-559, Case 24-2011, 2011
Cyclophosphamide Therapy in Pediatric Multiple Sclerosis
Neurol 72:2076-2082,2064, Makhani,N.,et al, 2009
Primary Angiitis of the Central Nervous System
Arch Neurol 66:704-709, Birnbaum,J. &Hellmann,D.B., 2009
Reduction of Disease Activity and Disability With High-Dose Cyclophosphamide in Patients With Aggressive Multiple Sclerosis
Arch Neurol 65:1044-1051, Krishnan,C.,et al., 2008
The Writing on the Wall
Lancet 372:344, Wilder-Smith,E.P. &Ng,E.S., 2008
Immunosuppressant Drugs for Myasthenia Gravis
JNNP 80:5-6, Hart,I.K.,et al, 2008
Vascultic Neuropathies: An Update
The Neurologist 13:12-19, Gorson,K.C., 2007
Intermittent Cyclophosphamide With Prednisone Versus Placebo for Polyneuropathy With IgM Monoclonal Gammopathy
Neurol 69:50-59, Niermeijer,J.M.F.,et al, 2007
Primary Central Nervous System Vasculitis: Analysis of 101 Patients
Ann Neurol 62:442-451,430, Salvarani,C.,et al, 2007
Clinicopath Conf., Multifocal Motor Neuropathy With Conduction Block
NEJM 357: 2707-2715, Case 40-2007, 2007
High-Dose Cyclophosphamide for Moderate to Severe Refractory Multiple Sclerosis
Arch Neurol 63:1388-1393, Gladstone,D.E.,et al, 2006
Update on Susacs Syndrome
Curr Opin Neurol 18:311-314, Gross,M. &Eliashar,R., 2005
Neurologic Manifestations in Primary Sjogren Syndrome: A Study of 82 Patients
Medicine 83:280-291, Delalande,S.,et al, 2004
Treatment of Refractory Myasthenia: "Rebooting" with High-Dose Cyclophosphamide
Ann Neurol 53:29-34,7, Drachman,D.B.,et al, 2003
Treatment of Autoimmune Myasthenia Gravis
Neurol 61:1652-1661, Richman,D.P. & Agius,M.A., 2003
High-dose Cyclophosphamide Without Stem-cell Rescue for Refractory CIDP
Neurol 58:1856-1858, Brannagan,T.H.,et al, 2002
Pachymeningitis and optic neuritis in Rheumatoid Arthritis: Successful Treatment with Cyclophosphamide
Clin Rheumatol 20:136-139, Yucel,A.E.,et al, 2001
Churg-Strauss Syndrome, Clinical Study and Long-Term Follow-Up of 96 Patients
Medicine 78:26-37, Guillevin,L.,et al, 1999
Isolated Angiitis of the Central Nervous System:Lack of Inflammation after Long-Term Treatment
Neurol 52:196-199, Reimer,G.,et al, 1999
Control of Primary Angiitis of the CNS Associated with Cerebral Amyloid Angiopathy by Cyclophosphamide Alone
Neurol 52:660-662, Fountain,N.B.&Lopes,B.S., 1999
Pulse Cyclophosphamide Therapy in Chronic Inflammatory Demyelinating Polyneuropathy
Neurol 51:1735-1738, Good,J.L.,et al, 1998
Diagnosis and Management of Neurological Sarcoidosis
Arch Int Med 157:1864-1868, Lower,E.E.,et al, 1997
Treatment of Inflammatory Myopathies
Muscle & Nerve 20:651-664997., Mastaglia,F.L.,et al, 1997
Management of Multiple Sclerosis
NEJM 337:1604-1611, Rudick,R.A.,et al, 1997
Intermittent Cyclophosphamide & Prednisone Trtm of Polyneuropathy Assoc with Monocl Gamopathy of Undeter Sign
Neurol 47:1227-1233, Notermans,N.C.,et al, 1996
Clinicopath Conf
Polyarteritis Nodosa, with Neuropathy, Case 40-1994, NEJM 331:1293-130094., , 1994
Intermittent Cyclophosphamide Pulse Therapy in Progressive MS:NE Coop MS Trtm Grp
Neurol 43:910-918, Weiner,H.L.,et al, 1993
The Canadian Coop Trial of Cyclophosphamide and Plasma Exchange in Progr MS
The Canadian Coop MS Study Group, Lancet 337:441-4461991., , 1991
The Use of Immunosuppressive Agents in the Treatment of Multiple Sclerosis:A Critical Review
Neurol 41:980-985, Goodin,D.S., 1991
Immunosuppressive Treatment in Multifocal Motor Neuropathy
Ann Neurol 30:397-401, Feldman,E.L.,et al, 1991
Intense Immunosuppression in Chronic Progressive Multiple Sclerosis:The Kaiser Study
JNNP 54:1055-1060, Likosky,W.H.,et al, 1991
Diagnosis and Management of Isolated Angiitis of the Central Nervous System
Neurol 39:167-173, Moore,P.M., 1989
Immunological Treatment for Multiple Sclerosis
Editorial, Lancet 1:699-7011989., , 1989
Immunotherapy of Multiple Sclerosis
Ann Neurol 23:211-223, Weiner,H.L.&Hafler,D.A., 1988
Controlled Pilot Trial of Monthly Intravenous Cyclophosphamide in Multiple Sclerosis
Arch Neurol 45:27-30, Killian,J.M.,et al, 1988
Treatment Response with Bilateral Mixed Deafness & Facial Palsy in Polyarteritis Nodosa
Am J Med 84:1081-1082, Vathenen,A.S.,et al, 1988
Cyclophosphamide"Pulses"in Chronic Progressive Multiple Sclerosis, A Preliminary Clinical Trial
Arch Neurol 44:828-832, Myers,L.W.,et al, 1987
Cyclophosphamide in Chronic Progressive Multiple Sclerosis, Maintenance vs Nonmaintenance Therapy
Arch Neurol 44:823-827, Goodkin,D.E.,et al, 1987
Immunosuppressive Drug Therapy in Myasthenia Gravis
Arch Neurol 43:155-156, Niakan,E.,et al, 1986
Isolated Angiitis of the Central Nervous System
Am J Med 74:97-105, Cupps,T.R.,et al, 1983
Intensive Immunosuppression in Progressive Multiple Sclerosis
NEJM 308:173-180, Hauser,S.L.,et al, 1983
Stable Remissions in Myasthenia Gravis
Neurol 31:32-37, Perez,M.C.,et al, 1981
Neurologic Manifestations of Systemic Vasculitis
Am J Med 71:517-524, Moore,P.M.,et al, 1981
Immunosppressive Agents in Corticosteroid-Refractory Childhood Dermatomyositis
Neurol 30:286-291, Niakan,E.,et al, 1980
Cyclophosphamide Therapy of Severe Systemic Necrotizing Vasculitis
NEJM 301:235-238, Fauci,A.S.,et al, 1979
Diabetes Insipidus Associated With Wegener's Granulomatosis Successfully Treated with Cyclophosphamide
NEJM 299:764, Haynes,B.F.,et al, 1978
Subacute meningitis heralding a diffuse granulomatous angiitis: (Wegener's granulomatosis? )
Neurol, 27:2621977., Atcheson,S.G.,et al, 1977